Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 633,145 |
|
|||||
| News | - | ||||||
| Day High | 32.1817 | Low High |
|||||
| Day Low | 31.05 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Biohaven Ltd | BHVN | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.87 | 2.78% | 32.11 | 18:06:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 31.49 | 31.05 | 32.1817 | 32.11 | 31.24 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,593 | 633,145 | $ 31.72 | $ 20,086,467 | - | 12.35 - 32.83 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:43:10 | 1 | $ 33.40 | USD |
Biohaven Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.58B | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Biohaven News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BHVN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 30.11 | 32.83 | 29.11 | 31.01 | 932,530 | 2.00 | 6.64% |
| 1 Month | 26.51 | 32.83 | 26.39 | 29.83 | 1,103,757 | 5.60 | 21.12% |
| 3 Months | 17.95 | 32.83 | 16.45 | 25.62 | 1,229,345 | 14.16 | 78.89% |
| 6 Months | 15.56 | 32.83 | 15.56 | 23.61 | 1,158,862 | 16.55 | 106.36% |
| 1 Year | 14.27 | 32.83 | 12.35 | 19.78 | 1,075,071 | 17.84 | 125.02% |
| 3 Years | 91.56 | 152.56 | 7.10 | 69.33 | 949,987 | -59.45 | -64.93% |
| 5 Years | 31.15 | 152.56 | 7.10 | 63.35 | 864,561 | 0.96 | 3.08% |
Biohaven Description
| Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. |
